This is what ideal medicine would look like: Doctors could specifically alter molecular processes in diseased cells in the body and thus causally cure patients. This is the goal of the German Centers for Health...
DZL scientist Dr. Bilal Alashkar Alhamwe is researching how exposure to the bacterium Acinetobacter lwoffii can protect us from chronic inflammatory diseases such as asthma.
Auto-antibodies can be frequent in severe disease progression, regardless of whether the disease is infectious or non-infectious. An international study with the participation of the DZL shows this.
DZL scientist Dr. Robert Prevedel has published a study that contributes to breakthrough improvements in a method of measuring cell stiffness.
DZL scientist Prof. Dr. Petros Christopoulos receives the 2022 Science Award of the German Cancer Society's Working Group for Internal Oncology (Arbeitsgemeinschaft Internistische Onkologie, AIO).
The German Research Foundation (DFG) announced that DZL scientist Fabian Theis is a winner of the Gottfried Wilhelm Leibniz prize. It is endowed with 2.5 million Euros.
Mukoviszidose e.V. is funding a project at Heidelberg University Hospital on the antibacterial effect of certain fatty acids upon the growth of pathogenic germs in the lungs.
On 21-23 November 2022, the DZL Academy hosted its Annual Symposium titled "Lung Development, Repair and Regeneration". In the suitably remote and beautiful grounds of Rauischholzhausen, about 50 early career scientists mingled and exchanged ideas...
Prof. Elie El Agha received the Justus Liebig University Giessen Award during the Academic Ceremony on November 25, 2022.
The German Center for Lung Research (DZL) will receive funding through the "Innovation Fund" of the German Centers for Health Research (DZG).
Six DZL scientists made it onto the list of most cited researchers worldwide in 2021.
Numerous DZL scientists contributed to the new guideline on lung cancer prevention, diagnosis, therapy, and follow-up.
